Ryman Healthcare Limited Stock Net Income
| RHCGF Stock | USD 1.41 0.00 0.00% |
As of the 12th of February 2026, Ryman Healthcare holds the Variance of 5.72, coefficient of variation of (812.40), and Risk Adjusted Performance of (0.09). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Ryman Healthcare, as well as the relationship between them. Please check Ryman Healthcare coefficient of variation, as well as the relationship between the total risk alpha and skewness to decide if Ryman Healthcare is priced some-what accurately, providing market reflects its current price of 1.41 per share. Please also confirm Ryman Healthcare information ratio, which is currently at (0.17) to check out the company can sustain itself at a future point.
Ryman Healthcare's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Ryman Healthcare's valuation are provided below:Ryman Healthcare Limited does not presently have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Ryman |
Ryman Healthcare 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ryman Healthcare's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ryman Healthcare.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in Ryman Healthcare on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Ryman Healthcare Limited or generate 0.0% return on investment in Ryman Healthcare over 90 days. Ryman Healthcare is related to or competes with Galapagos, Medicover, Ansell, Jinxin Fertility, Shandong Weigao, Medipal Holdings, and Shandong Weigao. Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the ... More
Ryman Healthcare Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ryman Healthcare's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ryman Healthcare Limited upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 19.43 |
Ryman Healthcare Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ryman Healthcare's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ryman Healthcare's standard deviation. In reality, there are many statistical measures that can use Ryman Healthcare historical prices to predict the future Ryman Healthcare's volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.32) | |||
| Total Risk Alpha | (0.59) | |||
| Treynor Ratio | (1.45) |
Ryman Healthcare February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (1.44) | |||
| Mean Deviation | 0.5798 | |||
| Coefficient Of Variation | (812.40) | |||
| Standard Deviation | 2.39 | |||
| Variance | 5.72 | |||
| Information Ratio | (0.17) | |||
| Jensen Alpha | (0.32) | |||
| Total Risk Alpha | (0.59) | |||
| Treynor Ratio | (1.45) | |||
| Maximum Drawdown | 19.43 | |||
| Skewness | (8.12) | |||
| Kurtosis | 66.0 |
Ryman Healthcare Backtested Returns
Ryman Healthcare maintains Sharpe Ratio (i.e., Efficiency) of -0.13, which implies the firm had a -0.13 % return per unit of risk over the last 3 months. Ryman Healthcare exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Ryman Healthcare's Coefficient Of Variation of (812.40), variance of 5.72, and Risk Adjusted Performance of (0.09) to confirm the risk estimate we provide. The company holds a Beta of 0.21, which implies not very significant fluctuations relative to the market. As returns on the market increase, Ryman Healthcare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Ryman Healthcare is expected to be smaller as well. At this point, Ryman Healthcare has a negative expected return of -0.31%. Please make sure to check Ryman Healthcare's information ratio, skewness, as well as the relationship between the Skewness and day median price , to decide if Ryman Healthcare performance from the past will be repeated at some point in the near future.
Auto-correlation | Huge |
Perfect predictability
Ryman Healthcare Limited has perfect predictability. Overlapping area represents the amount of predictability between Ryman Healthcare time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ryman Healthcare price movement. The serial correlation of 9.223372036854776E16 indicates that 9.223372036854776E16% of current Ryman Healthcare price fluctuation can be explain by its past prices.
| Correlation Coefficient | 92233.7 T | |
| Spearman Rank Test | -0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Ryman Healthcare Limited reported net income of 692.87 M. This is 103.02% higher than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The net income for all United States stocks is 21.35% lower than that of the firm.
Ryman Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ryman Healthcare's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Ryman Healthcare could also be used in its relative valuation, which is a method of valuing Ryman Healthcare by comparing valuation metrics of similar companies.Ryman Healthcare is currently under evaluation in net income category among its peers.
Ryman Fundamentals
| Return On Equity | 0.18 | |||
| Return On Asset | -7.0E-4 | |||
| Profit Margin | 1.13 % | |||
| Operating Margin | (0.02) % | |||
| Current Valuation | 4.01 B | |||
| Shares Outstanding | 500 M | |||
| Shares Owned By Insiders | 17.22 % | |||
| Shares Owned By Institutions | 26.40 % | |||
| Price To Earning | 11.98 X | |||
| Price To Book | 1.08 X | |||
| Price To Sales | 4.64 X | |||
| Revenue | 503.76 M | |||
| Gross Profit | 42.52 M | |||
| EBITDA | 788.44 M | |||
| Net Income | 692.87 M | |||
| Cash And Equivalents | 47.88 M | |||
| Cash Per Share | 0.10 X | |||
| Total Debt | 2.58 B | |||
| Debt To Equity | 0.76 % | |||
| Current Ratio | 0.71 X | |||
| Book Value Per Share | 7.26 X | |||
| Cash Flow From Operations | 585.98 M | |||
| Earnings Per Share | 0.77 X | |||
| Price To Earnings To Growth | 2.97 X | |||
| Number Of Employees | 6.8 K | |||
| Beta | 0.79 | |||
| Market Capitalization | 2.08 B | |||
| Total Asset | 10.97 B | |||
| Retained Earnings | 1.28 B | |||
| Working Capital | 114 M | |||
| Current Asset | 221 M | |||
| Current Liabilities | 107 M | |||
| Annual Yield | 0.04 % | |||
| Net Asset | 10.97 B | |||
| Last Dividend Paid | 0.22 |
About Ryman Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ryman Healthcare Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ryman Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ryman Healthcare Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Ryman Pink Sheet
Ryman Healthcare financial ratios help investors to determine whether Ryman Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ryman with respect to the benefits of owning Ryman Healthcare security.